ALIMERA SCIENCES INC Contracts & Agreements

First Amendment, dated as of 6, 2024, to the Amended and Restated Employment Agreement, dated as of December 11, 2023, by and between the Company and Richard S. Eiswirth, Jr (Filed With SEC on September 10, 2024)

First Amendment, dated as of 6, 2024, to Employment Agreement, dated as of January 2, 2024, by and between the Company and Elliot Maltz (Filed With SEC on September 10, 2024)

First Amendment, dated as of 6, 2024, to Employment Agreement, dated as of October 2, 2023, by and between the Company and Jason Werner (Filed With SEC on September 10, 2024)

First Amendment, dated as of 6, 2024, to Employment Agreement, dated as of December 11, 2023, by and between the Company and Todd Wood (Filed With SEC on September 10, 2024)

Letter Agreement, dated as of June 19, 2024, by and between Alimera Sciences, Inc. and SWK Funding LLC (Filed With SEC on August 7, 2024)

Manufacturing Services Agreement, dated as of July 17, 2024, by and between Alimera Sciences, Inc. and Alliance Medical Products, Inc. d.b.a. Siegfried Irvine (Filed With SEC on August 7, 2024)

Agreement and Plan of Merger (Filed With SEC on June 24, 2024)

Voting Agreement (Filed With SEC on June 24, 2024)

Seventh Amendment to Loan and Security Agreement dated as of March 6, 2024, by and among Alimera Sciences, Inc., SLR Investment Corp., as Collateral Agent, and the parties... (Filed With SEC on May 14, 2024)

Alimera Sciences, Inc. 2024 Equity Inducement Plan (Filed With SEC on February 9, 2024)

Form of Stock Option Agreement under the 2024 Equity Inducement Plan (Filed With SEC on February 9, 2024)

Form of Performance Stock Unit Agreement under the 2024 Equity Inducement Plan (Filed With SEC on February 9, 2024)

Form of Restricted Stock Unit Agreement under the 2024 Equity Inducement Plan (Filed With SEC on February 9, 2024)

Separation Agreement and General Release, dated January 2, 2024, by and between Alimera Sciences, Inc. and Russell Skibsted (Filed With SEC on January 4, 2024)

Employment Agreement, dated as of January 2, 2024, by and between Alimera Sciences, Inc. and Elliot Maltz (Filed With SEC on January 4, 2024)

Inducement Stock Option Agreement, dated as of January 2, 2024, by and between Alimera Sciences, Inc. and Elliot Maltz (Non-Plan Inducement Award) (Filed With SEC on January 4, 2024)

Amended and Restated Employment Agreement, dated as of December 11, 2023, by and between Alimera Sciences, Inc. and Richard S. Eiswirth, Jr (Filed With SEC on December 12, 2023)

Employment Agreement, dated as of December 11, 2023, by and between Alimera Sciences, Inc. and Todd Wood (Filed With SEC on December 12, 2023)

Inducement Stock Option Agreement, dated as of December 11, 2023, by and between Alimera Sciences, Inc. and Todd Wood (Non-Plan Inducement Award) (Filed With SEC on December 12, 2023)

Employment Agreement dated as of October 2, 2023 between Alimera Sciences, Inc. and Jason Werner (Filed With SEC on October 3, 2023)

Sixth Amendment to Loan and Security Agreement dated as of May 17, 2023, by and among Alimera Sciences, Inc., SLR Investment Corp., as Collateral Agent, and the parties signatory... (Filed With SEC on August 11, 2023)

Omnibus Exit Fee Agreement dated as of May 17, 2023, by and among Alimera Sciences, Inc., SLR Investment Corp., as Collateral Agent, and the parties signatory thereto as Lenders,... (Filed With SEC on August 11, 2023)

Joinder and Amendment to Registration Rights Agreement dated as of May 17, 2023, by and among Alimera Sciences, Inc. and the purchasers party thereto (Filed With SEC on August 11, 2023)

Form of Pre-Funded Warrant (Filed With SEC on August 2, 2023)

Alimera Sciences, Inc. 2023 Equity Incentive Plan and forms of award agreements thereunder (Filed With SEC on August 2, 2023)

Chairman Emeritus Agreement, dated as of August 1, 2023 by and between Alimera Sciences, Inc. and C. Daniel Myers (Filed With SEC on August 2, 2023)

Fifth Amendment to Loan and Security Agreement dated as of March 24, 2023, by and among Alimera Sciences, Inc., SLR Investment Corp, as Collateral Agent, and the parties signatory... (Filed With SEC on May 15, 2023)

Fifth Amendment Exit Fee Agreement dated as of March 24, 2023, by and among Alimera Sciences, Inc., SLR Investment Corp, as Collateral Agent, and the parties signatory thereto as... (Filed With SEC on May 15, 2023)

Fourth Amendment to Loan and Security Agreement dated as of December 7, 2022, by and among Alimera Sciences, Inc., SLR Investment Corp, as Collateral Agent, and the parties... (Filed With SEC on March 31, 2023)

Form of Warrant to Purchase Shares of Common Stock (Filed With SEC on March 27, 2023)

Securities Purchase Agreement, dated March 24, 2023, by and among Alimera Sciences, Inc. and the purchasers party thereto (Filed With SEC on March 27, 2023)

Registration Rights Agreement, dated March 24, 2023, by and among Alimera Sciences, Inc. and the purchasers party thereto (Filed With SEC on March 27, 2023)

Employment Agreement, dated January 9, 2023, by and between Alimera Sciences, Inc. and Russell L. Skibsted (Filed With SEC on January 10, 2023)

Third Amendment to Loan and Security Agreement dated February 22, 2022, by and among Alimera Sciences, Inc., SLR Investment Corp., as Collateral Agent, and the parties signatory... (Filed With SEC on May 12, 2022)

Description of Securities (Filed With SEC on March 23, 2022)

Change in Control Severance Agreement between Alimera Sciences, Inc., and Philip J. Ashman, Ph.D. as of July 16, 2021 (Filed With SEC on November 5, 2021)

Alimera Sciences, Inc. 2019 Omnibus Incentive Plan, as amended pursuant to stockholder approval on June 15, 2021 (Filed With SEC on June 16, 2021)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 7, 2021)

Share Purchase Agreement by and between Ocumension Therapeutics and Alimera Sciences, Inc., dated as of April 14, 2021 (Filed With SEC on April 14, 2021)

Voting and Investor Rights Agreement by and between Alimera Sciences, Inc. and Ocumension Therapeutics, dated as of April 14, 2021 (Filed With SEC on April 14, 2021)

Warrant Subscription Agreement by and between Alimera Sciences, Inc. and Ocumension Therapeutics, dated as of April 14, 2021 (Filed With SEC on April 14, 2021)

Exclusive License Agreement by and between and Ocumension (Hong Kong) Limited, dated as of April 14, 2021 (Filed With SEC on April 14, 2021)

Description of Securities (Filed With SEC on March 5, 2021)

Manufacturing Services Agreement between Alimera Sciences, Inc. and Cadence, Inc. dated October 30, 2020 (including related Supplier Quality Agreement) (Filed With SEC on November 3, 2020)

Employment Agreement, dated as of July 27, 2020, by and between Alimera Sciences, Inc. and Samer E. Kaba, M.D (Filed With SEC on November 3, 2020)

First Amendment to Restricted Stock Unit Award Agreement under 2010 Equity Incentive Plan of Richard S. Eiswirth, Jr (Filed With SEC on May 6, 2020)

Form of Restricted Stock Agreement under the Alimera Sciences, Inc. 2019 Omnibus Incentive Plan (Filed With SEC on May 6, 2020)

Form of Restricted Stock Unit Agreement under the Alimera Sciences, Inc. 2019 Omnibus Incentive Plan (Filed With SEC on May 6, 2020)

First Amendment to Loan and Security Agreement dated as of May 1, 2020, by and among Alimera Sciences, Inc., Solar Capital Ltd., as Collateral Agent, and the parties signatory... (Filed With SEC on May 1, 2020)

U.S. Small Business Administration Note dated April 21, 2020 of Alimera Sciences, Inc. in favor of HSBC Bank USA, National Association as the Lender (Filed With SEC on April 23, 2020)

Loan Agreement dated April 21, 2020 between HSBC Bank USA, National Association and Alimera Sciences, Inc (Filed With SEC on April 23, 2020)

Consent to Loan and Security Agreement dated as of April 21, 2020 by and among Alimera Sciences, Inc., Solar Capital Ltd., as collateral agent, and the Lenders parties thereto,... (Filed With SEC on April 23, 2020)

Description of Securities (Filed With SEC on March 2, 2020)

Exit Fee Agreement dated as of December 31, 2019, by and among Alimera Sciences, Inc., Solar Capital Ltd. as collateral agent, and the Lenders (Filed With SEC on January 6, 2020)

Loan and Security Agreement dated as of December 31, 2019, by and among Alimera Sciences, Inc., Solar Capital Ltd., as Collateral Agent, and the parties signatory thereto from... (Filed With SEC on January 6, 2020)

Registration Rights Agreement, dated as of October 24, 2019, between Alimera Sciences, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 25, 2019)

Purchase Agreement, dated as of October 24, 2019, between Alimera Sciences, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 25, 2019)

Form of Alimera Sciences, Inc. Deduction Agreement (Filed With SEC on September 5, 2019)

Alimera Sciences, Inc. 2019 Non-Employee Director Compensation Program (Filed With SEC on July 19, 2019)

Alimera Sciences, Inc. 2019 Omnibus Incentive Plan (Filed With SEC on June 19, 2019)

Form of Stock Option Agreement under the Alimera Sciences, Inc. 2019 Omnibus Incentive Plan (Filed With SEC on June 19, 2019)

Amended and Restated Employment Agreement, dated as of January 2, 2019, by and between Alimera Sciences, Inc. and Richard S. Eiswirth, Jr (Filed With SEC on May 8, 2019)

Amended and Restated Employment Agreement, dated as of January 2, 2019, by and between Alimera Sciences, Inc. and J. Philip Jones (Filed With SEC on May 8, 2019)

Amended and Restated Succession and Consulting Agreement, dated as of March 27, 2019, by and between Alimera Sciences, Inc. and Kenneth Green, Ph.D (Filed With SEC on May 7, 2019)

Office Lease by and between Rubicon, L.C. and Alimera Sciences, Inc., dated as of May 27, 2003, as amended on various dates through August 14, 2014 (Filed With SEC on February 25, 2019)

Succession and Consulting Agreement, dated as of November 28, 2018, by and between Alimera Sciences, Inc. and C. Daniel Myers (Filed With SEC on November 29, 2018)

Succession and Consulting Agreement, dated as of November 28, 2018, by and between Alimera Sciences, Inc. and Kenneth Green, Ph.D (Filed With SEC on November 29, 2018)

Series B Preferred Stock Exchange Agreement, dated as of September 4, 2018, by and among Alimera Sciences, Inc., and Deerfield Special Situations Fund, L.P., Deerfield Private... (Filed With SEC on September 5, 2018)

Loan and Security Agreement dated as of January 5, 2017, among Alimera Sciences, Inc., Solar Capital Ltd., as Collateral Agent, and the parties signatory thereto from time to time... (Filed With SEC on January 8, 2018)

Exit Fee Agreement dated as of January 5, 2018 by and among Alimera Sciences, Inc., Solar Capital Ltd. as collateral agent, and the Lenders (Filed With SEC on January 8, 2018)

Common Stock Sales Agreement by and between Alimera Sciences, Inc. and H.C. Wainwright & Co., LLC dated October 20, 2017 (Filed With SEC on October 20, 2017)

2017 AMENDMENT TO AMENDED AND RESTATED COLLABORATION AGREEMENT (Filed With SEC on August 10, 2017)

FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 10, 2017)

UK SUB-PLAN TO THE ALIMERA SCIENCES, INC. 2010 EQUITY INCENTIVE PLAN Additional Terms and Conditions for Options received by Employees Resident in the UK (Filed With SEC on March 3, 2017)

ALIMERA SCIENCES, INC. 2010 EQUITY INCENTIVE PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD (Filed With SEC on March 3, 2017)

AMENDMENT NO. 3 TO WARRANT AGREEMENT (Filed With SEC on November 4, 2016)

WARRANT AGREEMENT To Purchase Shares of the Common Stock of Alimera Sciences, Inc. Dated as of October 20, 2016 (the Effective Date) (Filed With SEC on November 4, 2016)

WAIVER (Filed With SEC on November 4, 2016)

FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 4, 2016)

18,000,000 SHARES ALIMERA SCIENCES, INC. COMMON STOCK UNDERWRITING AGREEMENT (Filed With SEC on August 11, 2016)

THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 27, 2016)

AMENDMENT NO. 2 TO WARRANT AGREEMENT (Filed With SEC on May 6, 2016)

CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on May 6, 2016)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 6, 2016)

AMENDMENT NO. 1 TO WARRANT AGREEMENT (Filed With SEC on March 15, 2016)

ALIMERA SCIENCES INC. 2010 EQUITY INCENTIVE PLAN ADDENDUM Terms and Conditions for French Option Grants (Filed With SEC on March 15, 2016)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 15, 2016)

AMENDMENT NO. 1 TO THE ALIMERA SCIENCES, INC. 2010 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on March 13, 2015)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT WITH ALIMERA SCIENCES, INC. (Filed With SEC on March 13, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 15, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 28, 2014)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT WITH ALIMERA SCIENCES, INC. (Filed With SEC on October 23, 2014)

ALIMERA SCIENCES, INC. $35,000,000 SALES AGREEMENT (Filed With SEC on September 22, 2014)

WARRANT AGREEMENT To Purchase Shares of the Common Stock of Alimera Sciences, Inc. Dated as of April 24, 2014 (the Effective Date) (Filed With SEC on August 11, 2014)

LOAN AND SECURITY AGREEMENT (Filed With SEC on August 11, 2014)

UNCONDITIONAL GUARANTY (Filed With SEC on August 11, 2014)

IRREVOCABLE WAIVER OF RIGHT TO DESIGNATE SERIES A DIRECTOR May 16, 2014 (Filed With SEC on May 16, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 28, 2014)

AMENDMENT NO. 1 TO WARRANT TO PURCHASE STOCK (Filed With SEC on August 14, 2013)

LOAN AND SECURITY AGREEMENT (Filed With SEC on August 14, 2013)

SECURITY AGREEMENT (Filed With SEC on August 14, 2013)

UNCONDITIONAL GUARANTY (Filed With SEC on August 14, 2013)

SECOND LOAN MODIFICATION AGREEMENT (WORKING CAPITAL LINE OF CREDIT) (Filed With SEC on August 14, 2013)

CONTRACT OF EMPLOYMENT (Filed With SEC on March 28, 2013)

EXHIBIT 10.41 CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 28, 2013)

UK SUB-PLAN OF THE 2010 EQUITY INCENTIVE PLAN OF ALIMERA SCIENCES, INC. (Filed With SEC on November 7, 2012)

UK SUB-PLAN TO THE ALIMERA SCIENCES, INC. 2010 EQUITY INCENTIVE PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on November 7, 2012)

ALIMERA SCIENCES, INC. WARRANT TO PURCHASE SHARES OF SERIES A PREFERRED STOCK (Filed With SEC on October 2, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 2, 2012)

AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 2, 2012)

Interim Condensed Consolidated Financial Statements (unaudited) (Filed With SEC on August 14, 2012)

ALIMERA SCIENCES, INC. WARRANT TO PURCHASE SHARES OF SERIES A PREFERRED STOCK (Filed With SEC on July 18, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 18, 2012)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 18, 2012)

Manufacturing Services Agreement (Filed With SEC on May 11, 2012)

ALIMERA SCIENCES, INC. 2010 EQUITY INCENTIVE PLAN: NOTICE OF STOCK UNIT AWARD (Filed With SEC on March 30, 2012)

EX-101 INSTANCE DOCUMENT (Filed With SEC on August 5, 2011)

WARRANT TO PURCHASE STOCK (Filed With SEC on May 17, 2011)

FIRST LOAN MODIFICATION AGREEMENT (Filed With SEC on May 17, 2011)

delay in or failure to obtain regulatory approval of the Companys product candidates (Filed With SEC on March 25, 2011)

Entry into a Definitive Material Agreement (Filed With SEC on October 18, 2010)

CONFIDENTIAL TREATMENT REQUESTED COMMERCIAL CONTRACT MANUFACTURING AGREEMENT Dated as of February 5, 2010 By and Between Alimera Sciences, Inc. And Alliance Medical Products, Inc. (Filed With SEC on March 19, 2010)

Pursue FDA Approval for Iluvien. In December 2009 we received the month 24 clinical readout from our FAME Study. Based upon our analysis of this data, we plan to file an NDA in... (Filed With SEC on March 15, 2010)

Pursue FDA Approval for Iluvien. In December 2009 we received the month 24 clinical readout from our FAME Study. Based upon our analysis of this data, we plan to file an NDA in... (Filed With SEC on December 23, 2009)

EX-10.12 COMPENSATION PROGRAM FOR NON-EMPLOYEE DIRECTORS (Filed With SEC on October 30, 2009)

Pursue FDA Approval for Iluvien. In the fourth quarter of 2009 we will receive a month 24 readout from the FAME Study. Based on an analysis of this readout we plan to pursue an... (Filed With SEC on October 30, 2009)

EX-10.2.A: AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 19, 2008)

EX-10.3.A: AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 19, 2008)

EX-10.4.A: AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 19, 2008)

EX-10.5.A: AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 19, 2008)

EX-10.6.A: AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 19, 2008)

EX-10.12:AMENDED AND RESTATED COLLABORATION AGREEMENT (Filed With SEC on August 19, 2008)

EX-10.13:ASSET PURCHASE AGREEMENT DATED DECEMBER 20, 2006 (Filed With SEC on August 19, 2008)

EX-10.14:ASSET PURCHASE AGREEMENT DATED FEBRUARY 16, 2007 (Filed With SEC on August 19, 2008)

EX-10.15:OPTION AGREEMENT DATED AUGUST 31, 2008 (Filed With SEC on August 19, 2008)

EX-10.16:OPTION AGREEMENT DATED FEBRUARY 1, 2008 (Filed With SEC on August 19, 2008)

EX-10.24:LICENSE AGREEMENT (Filed With SEC on August 19, 2008)

EX-4.3: SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on July 1, 2008)

EX-4.4: SECOND AMENDED AND RESTATED STOCK SALE AGREEMENT (Filed With SEC on July 1, 2008)

EX-10.1: FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on July 1, 2008)

EX-10.2: EMPLOYMENT AGREEMENT-MYERS (Filed With SEC on July 1, 2008)

EX-10.3: EMPLOYMENT AGREEMENT-EISWIRTH (Filed With SEC on July 1, 2008)

EX-10.4: EMPLOYMENT AGREEMENT-HOLLAND (Filed With SEC on July 1, 2008)

EX-10.5: EMPLOYMENT AGREEMENT-CABALLA (Filed With SEC on July 1, 2008)

EX-10.6: EMPLOYMENT AGREEMENT-GREEN (Filed With SEC on July 1, 2008)

EX-10.7: 2004 INCENTIVE STOCK PLAN (Filed With SEC on July 1, 2008)

EX-10.7.A.: FORM OF OPTION CERTIFICATE (Filed With SEC on July 1, 2008)

EX-10.8: 2005 INCENTIVE STOCK PLAN (Filed With SEC on July 1, 2008)

EX-10.8.A.: FORM OF OPTION CERTIFICATE (Filed With SEC on July 1, 2008)

EX-10.9: 2008 EQUITY INCENTIVE PLAN (Filed With SEC on July 1, 2008)

EX-10.10: 2008 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on July 1, 2008)

EX-10.11: MANAGEMENT CASH INCENTIVE PLAN (Filed With SEC on July 1, 2008)

EX-10.17: OFFICE LEASE (Filed With SEC on July 1, 2008)

EX-10.18: OPTION CERTIFICATES (Filed With SEC on July 1, 2008)

EX-10.19: OPTION CERTIFICATES (Filed With SEC on July 1, 2008)

EX-10.20: OPTION CERTIFICATES (Filed With SEC on July 1, 2008)

EX-10.21: OPTION CERTIFICATES (Filed With SEC on July 1, 2008)

EX-10.22: OPTION CERTIFICATES (Filed With SEC on July 1, 2008)

EX-10.23: OPTION CERTIFICATES (Filed With SEC on July 1, 2008)

Category

Industry

Companies

Contracts

ALIMERA SCIENCES INC Contracts & Agreements